Intec Pharma Ltd
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$14,128,000 over the previous period. Total operating expenses were $13,829,000.

Profit Margin

Intec Pharma Ltd (NASDAQ:NTEC): Profit margin
2013 0 -5.28M
2014 0 -5.69M
2015 0 -7.14M
2016 0 -13.36M
2017 0 -29.09M
2018 0 -43.54M
2019 0 -47.59M
2020 0 -14.12M

NTEC Income Statement (2013 – 2020)

2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
00000000
Cost of revenue
00000000
Gross profit
00000000
Operating exp.
Research and development
6.74M26.65M35.40M24.29M10.74M4.79M3.40M2.58M
Selling and marketing
00000000
Total operating expenses
13.82M33.44M43.32M29.41M13.82M7.54M5.99M5.33M
Operating income
-13.82M-33.44M-43.32M-29.43M-13.84M-7.56M-6.01M-5.35M
Other income (expenses), net
-175K-13.51M-112K375K484K421.39K325K74.65K
Income before tax
-14.00M-46.96M-43.44M-29.06M-13.36M-7.14M-5.69M-5.28M
Income tax expense
124K638K103K29K500K436.76K348K99.06K
Net income
-14.12M-47.59M-43.54M-29.09M-13.36M-7.14M-5.69M-5.28M
Earnings per share
Basic EPS
-14.3-112.74-111.67-131.79-93.38-73.35-94.39-97.75
Diluted EPS
-14.3-112.74-111.67-131.79-93.38-73.35-94.39-97.75
Data sourceData source